Resources

The Undisputed, Nearly Undefeated Champion Predictor of Financial Risk
Blog Post

When the FRISK® score becomes your go-to metric for financial risk analysis, incredibly accurate (read: good) adjustments follow.

Quorum Health Corporation
High Risk Report

It's unhealthy to think public company bankruptcy risk is a myth -- we show you why in this High Risk Report focusing on Quorum Health Corporation.

Pharmaceutical Risk
Blog Post

Two major U.S. pharmaceutical companies possess heightened bankruptcy risk largely due to lawsuits stemming from the opioid crisis. Our models are reflexive enough to give the most accurate forward-looking reads on financial risk when calamities strike.

FRISK® Score Predicts Recent Bankruptcies
Brochure

Over the last two completed calendar years, CreditRiskMonitor's FRISK® score was able to predict U.S. public company bankruptcy at a near 98% rate of success.

PAYCE® Score
Blog Post

As part of our look back at the year that was in 2018, the arrival of the PAYCE® score changed the way our subscribers monitored private company financial risk.

Akorn, Inc.
High Risk Report

Chicago-based pharmaceutical leader Akorn, Inc. has seen its FRISK® score freefall down from a "9" to a "1" in a year's time.

Community Health Systems, Inc.
High Risk Report

Is Community Health Systems, Inc. on life support? Our High Risk Report offers a prognosis on this volatile American healthcare provider.

Assessing Contraction Risk: The Healthcare Sector
Blog Post

A contraction in credit is not something that might occur: It will happen at some point. Risk professionals dealing with the healthcare sector are better off preparing now, while economic conditions are still strong.

Hooper Holmes, Inc.
Bankruptcy Case Studies

CreditRiskMonitor’s FRISK® score had been warning of tremendous financial stress at healthcare provider Hooper Holmes, Inc. for more than a year's time before their bankruptcy filing in late August.

Orexigen Therapeutics, Inc.
Bankruptcy Case Studies

California-based biopharmaceutical company Orexigen Therapeutics, Inc. failed to pass our FRISK® score inspection for years, ultimately filing for bankruptcy in early 2018.

The FRISK® Score Predicts Scorecard
Brochure

A recent study of the last two completed calendar years showed that CreditRiskMonitor's FRISK® score was able to predict U.S. public company bankruptcy at a 97.9% rate of success.

Genesis Healthcare
Blog Post

In 2016, there were more than 50 million people 65-or-older living in the United States. Although the post-acute healthcare industry is still growing along with its prime customer base, this fiercely competitive service industry remains a highly fragmented market.

Pages

Subscribe to Healthcare